Navigation Links
Wayne State University researcher to study spinal muscular atrophy
Date:9/9/2011

DETROIT Graham Parker, Ph.D., assistant professor of research in the Department of Pediatrics at Wayne State University's School of Medicine, was awarded $418,000 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health to study how a particular gene might be involved in the progression of spinal muscular atrophy (SMA) the number one genetic killer of children younger than 2 years old.

"Although most people have never heard of it, SMA is the most prevalent hereditary motor neuron disease, affecting four to 10 per 100,000 live births, with as many as one in 75 people being carriers of the genetic mutation," said Parker.

There is no cure for or treatment to slow the progression of SMA, but Parker and co-investigator Gyula Acsadi, M.D., Ph.D., associate professor of pediatrics and neurology, hope to clarify the role of alpha-synuclein (SNCA), which they believe is a potentially significant genetic biomarker of the neuromuscular disease. A better understanding of SNCA's role may help develop new therapies to treat SMA.

Spinal muscular atrophy is characterized by diseased motor neurons in the spinal cord. Typically, these motor neurons send signals to various muscles throughout the body, like those that control breathing. But in the diseased state, the neurons degenerate and die, resulting in muscle weakness of varied severity.

So, what causes the motor neurons to become diseased in the first place? "The genetic cause of SMA is well established: the lowering of survival motor neuron (SMN) protein, which exists in all cells," said Parker. "But we still have no idea why SMN loss specifically affects the motor neurons in this way."

Evidence from their previous research, however, points toward SNCA.

"Our analyses of SMN-deficient neuronal cells discovered that low levels of SMN are associated with reduced SNCA gene expression," he said. "Recent work has indicated that downregulation of SNCA can compromise the viability of neural cells."

In this study, Parker will put SNCA to the test. He aims to determine whether dramatically decreasing SNCA expression levels will mimic the motor neuron death observed under SMA conditions. He will then increase SNCA expression levels to see if this slows the progression of SMA.

Parker expects his findings to come with important implications for the discovery of new therapies. "The knowledge gained from this research is a highly desirable goal, potentially allowing us to identify more useful disease markers for future clinical trials, as well as develop new models to advance neuromuscular disease research," said Parker.


'/>"/>

Contact: Julie O'Connor
julie.oconnor@wayne.edu
313-577-8845
Wayne State University - Office of the Vice President for Research
Source:Eurekalert

Related medicine news :

1. Wayne State University awarded $3 million from NIH to foster science and research careers
2. Wayne State researcher receives NSF award to develop neural implants
3. Wayne State University engineering student receives American Tinnitus Association award
4. Wayne State University researcher argues that sex reduces genetic variation
5. Health providers should emphasize breast cancer screening, Wayne State University research finds
6. Religion benefits traumatic brain injury victims, Wayne State University research finds
7. Wayne State University researchers win grant from the NSF to target tinnitus
8. Wayne State researchers find new way to examine major depressive disorder in children
9. Wayne State leads study to improve management of cancer pain in African Americans
10. Wayne State study links testosterone with mens ability to woo potential mates
11. Wayne State University researchers publish results settling multiple sclerosis debate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... the organization behind the New England Journal of Medicine and NEJM Journal Watch, ... Knowledge+ Pediatrics Board Review was created by a panel of pediatricians from leading ...
(Date:3/27/2017)... ... 27, 2017 , ... Osteitis pubis may be commonplace and ... it occurs when the muscles around the pelvis become inflamed. Over time, untreated ... torso, as well as accompanying tenderness and weakness. Without proper intervention, it can ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... announce that for a second year in a row; they are the recipient ... designers in the industry voted on the award at Design Connections 2017. Top ...
(Date:3/27/2017)... ... , ... The Anaheim Hills office accelerates and supports FNCC’s growth and further ... sales professionals over the past 6 months and is continuing to recruit new talent ... course of 2017. , “This new office is a direct result of our ...
(Date:3/27/2017)... ... 27, 2017 , ... Golden Triangle Emergency Center will be ... 3rd to commemorate the two-year anniversary of the facility. The event will feature ... great years while also familiarizing themselves with the facility. , In the two ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017 The ... reach USD 16.0 billion by 2025, according to a ... prevalence of chronic diseases is anticipated to be responsible ... which thereby widens the scope for growth during the ... bariatric population, which is highly susceptible to chronic diseases, ...
(Date:3/27/2017)...  Twist Bioscience, a company accelerating science and innovation ... raised an additional $33 million. To date, Twist Bioscience ... "It is an exciting time to be leading ... to deliver industry-leading gene volume to our customers, enabling ... Leproust, Ph.D., CEO of Twist Bioscience. "We welcome the ...
(Date:3/27/2017)... , March 27, 2017   Genprex, Inc. , a ... Julien Pham , MD, the Company,s Chief Operating Officer, is ... conferences. Sachs 5th Annual Cancer BioPartnering & Investment ... New York, NY ... BioCentury 24th Annual Future Leaders in Biotech ...
Breaking Medicine Technology: